Popat S - Search Results

1

CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations.

Felip E, Ardizzoni A, Ciuleanu T, Cobo M, Laktionov K, Szilasi M, Califano R, Carcereny E, Griffiths R, Paz-Ares L, Duchnowska R, Garcia MA, Isla D, Jassem J, Appel W, Milanowski J, Van Meerbeeck JP, Wolf J, Li A, Acevedo A, Popat S. Felip E, et al. Among authors: popat s. Eur J Cancer. 2020 Mar;127:160-172. doi: 10.1016/j.ejca.2019.11.019. Epub 2020 Feb 3. Eur J Cancer. 2020. PMID: 32028209 Free article. Clinical Trial.

2

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis.

Popat S, Houlston RS. Popat S, et al. Eur J Cancer. 2005 Sep;41(14):2060-70. doi: 10.1016/j.ejca.2005.04.039. Eur J Cancer. 2005. PMID: 16125380 Review.

3

Time and chemotherapy treatment trends in the treatment of elderly patients (age >/=70 years) with small cell lung cancer.

Yau T, Ashley S, Popat S, Norton A, Matakidou A, Coward J, O'Brien ME. Yau T, et al. Among authors: popat s. Br J Cancer. 2006 Jan 16;94(1):18-21. doi: 10.1038/sj.bjc.6602888. Br J Cancer. 2006. PMID: 16317431 Free PMC article.

4

Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival.

Sirohi B, Ashley S, Norton A, Popat S, Hughes S, Papadopoulos P, Priest K, O'Brien M. Sirohi B, et al. Among authors: popat s. J Thorac Oncol. 2007 Aug;2(8):735-40. doi: 10.1097/JTO.0b013e31811f3a7d. J Thorac Oncol. 2007. PMID: 17762340 Free article.

5

Time and chemotherapy treatment trends in the treatment of elderly patients (age>or=70 years) with non-small cell lung cancer.

O'Brien ME, Yau T, Coward J, Hughes S, Papadopoulos P, Popat S, Norton A, Ashley S. O'Brien ME, et al. Among authors: popat s. Clin Oncol (R Coll Radiol). 2008 Mar;20(2):142-7. doi: 10.1016/j.clon.2007.11.007. Clin Oncol (R Coll Radiol). 2008. PMID: 18093813

6

Platinum-based chemotherapy in triple-negative breast cancer.

Sirohi B, Arnedos M, Popat S, Ashley S, Nerurkar A, Walsh G, Johnston S, Smith IE. Sirohi B, et al. Among authors: popat s. Ann Oncol. 2008 Nov;19(11):1847-52. doi: 10.1093/annonc/mdn395. Epub 2008 Jun 20. Ann Oncol. 2008. PMID: 18567607 Free article.

7

The combination of Young's syndrome and small cell lung cancer-A spiky connection?

Forster M, Enting D, Nicholson AG, O'Brien M, Popat S. Forster M, et al. Among authors: popat s. Lung Cancer. 2010 Mar;67(3):372-5. doi: 10.1016/j.lungcan.2009.10.011. Epub 2009 Dec 1. Lung Cancer. 2010. PMID: 19954857

8

Treatment options for small cell lung cancer - do we have more choice?

Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, O'Brien ME. Puglisi M, et al. Among authors: popat s. Br J Cancer. 2010 Feb 16;102(4):629-38. doi: 10.1038/sj.bjc.6605527. Epub 2010 Jan 26. Br J Cancer. 2010. PMID: 20104223 Free PMC article. Review.

9

Modest reductions in dose intensity and drug-induced neutropenia have no major impact on survival of patients with non-small cell lung cancer treated with platinum-doublet chemotherapy.

Brunetto AT, Carden CP, Myerson J, Faria AL, Ashley S, Popat S, O'Brien ME. Brunetto AT, et al. Among authors: popat s. J Thorac Oncol. 2010 Sep;5(9):1397-403. doi: 10.1097/JTO.0b013e3181eba7f9. J Thorac Oncol. 2010. PMID: 20644495 Free article.

10

Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Myerson JS, Iqbal SA, O'Brien ME, Popat S. Myerson JS, et al. Among authors: popat s. Clin Lung Cancer. 2010 Sep 1;11(5):E5-8. doi: 10.3816/CLC.2010.n.047. Clin Lung Cancer. 2010. PMID: 20837451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

403 results

Search Page